Vivos 2025 Q2 Earnings Continued Losses Despite EPS Improvement
Generated by AI AgentAinvest Earnings Report Digest
Wednesday, Aug 20, 2025 3:07 am ET1min read
VVOS--
Aime Summary
Vivos (VVOS) reported its fiscal 2025 Q2 earnings on August 19, 2025. The company narrowly improved its earnings per share, but the net loss expanded significantly, missing the expectations for meaningful financial recovery.
Revenue
Vivos saw a 5.8% year-over-year decline in total revenue, which fell to $3.82 million in the second quarter of 2025, compared to $4.05 million in the same period the prior year. Product sales contributed $1.89 million, including $1.03 million in appliances and $857,000 in guides. Service revenue totaled $1.94 million, driven by $844,000 in sleep testing services, $163,000 in myofunctional therapy, $190,000 in billing intelligence services, and $130,000 in VIP services. Additional revenue came from sponsorship, seminars, and other activities, amounting to $608,000. Overall, the mix of product and service offerings reflects a diversified revenue base, although the decline in total revenue underscores ongoing market challenges.
Earnings/Net Income
Vivos posted a narrowing loss per share, improving from $0.60 in Q2 2024 to $0.55 in Q2 2025, a 8.3% improvement. However, the company’s net loss expanded to $5.01 million in the latest quarter, a 159.7% increase compared to $1.93 million in the prior-year period. The company has now posted losses in six consecutive years in the same quarter, highlighting persistent financial difficulties and the need for a more sustainable path to profitability.
Price Action
The stock has continued to underperform in the short term, with a 3.83% drop in a single trading day, a 10.11% decline over the past week, and a 26.63% drop month-to-date.
Post-Earnings Price Action Review
Despite the continued losses, the earnings event-driven strategy of buying VivosVVOS-- shares at the time of the report and holding for 30 days has historically shown strong returns. Over the past three years, this strategy delivered a 136.52% return, outperforming the benchmark by 71.82%. While the compound annual growth rate (CAGR) was 39.91%, the strategy came with high volatility—182.10%—and a Sharpe ratio of 0.22, suggesting that the returns were achieved with considerable risk.
Additional News
A tragic series of attacks in Bokkos Local Government Area of Plateau State on July 24 and 25, 2025, resulted in the deaths of 14 villagers and a mobile police officer. The first incident occurred early in the morning when a police officer was killed at a checkpoint along Richa Road. Later the same day, at approximately 4:00 pm, suspected terrorists ambushed a group of villagers returning from the market, killing 14 people and injuring three. The local community confirmed the attacks, with leaders describing the situation as an emergency. Security forces have been deployed to the area in response. Local residents have called on the federal government to establish state police to enhance security and prevent further violence.
Revenue
Vivos saw a 5.8% year-over-year decline in total revenue, which fell to $3.82 million in the second quarter of 2025, compared to $4.05 million in the same period the prior year. Product sales contributed $1.89 million, including $1.03 million in appliances and $857,000 in guides. Service revenue totaled $1.94 million, driven by $844,000 in sleep testing services, $163,000 in myofunctional therapy, $190,000 in billing intelligence services, and $130,000 in VIP services. Additional revenue came from sponsorship, seminars, and other activities, amounting to $608,000. Overall, the mix of product and service offerings reflects a diversified revenue base, although the decline in total revenue underscores ongoing market challenges.
Earnings/Net Income
Vivos posted a narrowing loss per share, improving from $0.60 in Q2 2024 to $0.55 in Q2 2025, a 8.3% improvement. However, the company’s net loss expanded to $5.01 million in the latest quarter, a 159.7% increase compared to $1.93 million in the prior-year period. The company has now posted losses in six consecutive years in the same quarter, highlighting persistent financial difficulties and the need for a more sustainable path to profitability.
Price Action
The stock has continued to underperform in the short term, with a 3.83% drop in a single trading day, a 10.11% decline over the past week, and a 26.63% drop month-to-date.
Post-Earnings Price Action Review
Despite the continued losses, the earnings event-driven strategy of buying VivosVVOS-- shares at the time of the report and holding for 30 days has historically shown strong returns. Over the past three years, this strategy delivered a 136.52% return, outperforming the benchmark by 71.82%. While the compound annual growth rate (CAGR) was 39.91%, the strategy came with high volatility—182.10%—and a Sharpe ratio of 0.22, suggesting that the returns were achieved with considerable risk.
Additional News
A tragic series of attacks in Bokkos Local Government Area of Plateau State on July 24 and 25, 2025, resulted in the deaths of 14 villagers and a mobile police officer. The first incident occurred early in the morning when a police officer was killed at a checkpoint along Richa Road. Later the same day, at approximately 4:00 pm, suspected terrorists ambushed a group of villagers returning from the market, killing 14 people and injuring three. The local community confirmed the attacks, with leaders describing the situation as an emergency. Security forces have been deployed to the area in response. Local residents have called on the federal government to establish state police to enhance security and prevent further violence.

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet